SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008069
Filing Date
2024-05-14
Accepted
2024-05-14 08:35:59
Documents
47
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apre-20240331x10q.htm   iXBRL 10-Q 1281226
2 EX-10.4 apre-20240331xex10d4.htm EX-10.4 109632
3 EX-10.5 apre-20240331xex10d5.htm EX-10.5 64482
4 EX-10.6 apre-20240331xex10d6.htm EX-10.6 62374
5 EX-31.1 apre-20240331xex31d1.htm EX-31.1 10250
6 EX-31.2 apre-20240331xex31d2.htm EX-31.2 10536
7 EX-32.1 apre-20240331xex32d1.htm EX-32.1 6698
8 EX-32.2 apre-20240331xex32d2.htm EX-32.2 6712
  Complete submission text file 0001558370-24-008069.txt   3883061

Data Files

Seq Description Document Type Size
9 EX-101.SCH apre-20240331.xsd EX-101.SCH 24629
10 EX-101.CAL apre-20240331_cal.xml EX-101.CAL 27547
11 EX-101.DEF apre-20240331_def.xml EX-101.DEF 91733
12 EX-101.LAB apre-20240331_lab.xml EX-101.LAB 225807
13 EX-101.PRE apre-20240331_pre.xml EX-101.PRE 153222
51 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240331x10q_htm.xml XML 262288
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39069 | Film No.: 24941573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)